The effects of prognostic factors on transplant and mortality of patients with end-stage liver disease using Markov multistate model

被引:0
|
作者
Madreseh, Elham [1 ,2 ]
Mahmoudi, Mahmood [1 ]
Toosi, Mohssen Nassiri [3 ]
Abolghasemi, Jamileh [4 ]
Zeraati, Hojjat [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran
[2] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Liver Transplantat Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran
[4] Iran Univ Med Sci, Sch Publ Hlth, Dept Biostat, Tehran, Iran
来源
关键词
Cirrhosis; life expectancy; model for end-stage liver disease; survival; LONG-TERM SURVIVAL; WAITING-LIST; LIFE EXPECTANCY; MELD; RECIPIENTS; CIRRHOSIS; SCORE; BENEFIT; HEALTH; STATES;
D O I
10.4103/jrms.jrms_1091_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Decompensated cirrhosis patients have a high risk of death which can be considerably reduced with liver transplantation (LT). This study aimed to simultaneously investigate the effect of some patients' characteristics on mortality among those with/without LT and also LT incident.Materials and Methods: In this historical cohort study, the information from 780 eligible patients aged 18 years or older was analyzed by the Markov multistate model; they had been listed between 2008 and 2014, needed a single organ for initial orthotopic LT, and followed at least for up to 5 years.Results: With a median survival time of 6 (5-8) years, there were 275 (35%) deaths. From 255 (33%) patients who had LT, 55 (21%) subsequently died. Factors associated with a higher risk of mortality and LT occurrence were included: higher model for end-stage liver disease (MELD) score (hazard ratio [HR] = 1.16, confidence interval [CI]: 1.09-1.24 and HR = 1.22, CI: 1.41-1.30) and ascites complication (HR = 2.34, CI: 1.74-3.16 and HR = 11.43, CI: 8.64-15.12). Older age (HR = 1.03, CI: 1.01-1.06), higher creatinine (HR = 6.87, CI: 1.45-32.56), and autoimmune disease versus hepatitis (HR = 2.53, CI: 1.12-5.73) were associated with increased risk of mortality after LT.Conclusion: The MELD and ascites are influential factors on waiting list mortality and occurrence of LT. Total life expectancy is not influenced by higher MELD.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Prognostic Value of Model for End-Stage Liver Disease Scores in Patients with Fulminant Hepatic Failure
    Lee, H. S.
    Choi, G. H.
    Joo, D. J.
    Kim, M. S.
    Kim, S. I.
    Han, K. H.
    Ahn, S. H.
    Kim, D. Y.
    Park, J. Y.
    Choi, J. S.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (08) : 2992 - 2994
  • [32] RISK FACTORS FOR MORTALITY IN PATIENTS WITH SCHIZOPHRENIA AND END-STAGE RENAL DISEASE
    Jackson, A. J.
    Colombo, R.
    Baer, S.
    Young, L.
    Waller, J.
    Kheda, M.
    Nahman, S.
    Spearman, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (02) : 599 - 599
  • [33] A model to predict survival in patients with End-Stage Liver Disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, WK
    Therneau, TM
    D'Amico, G
    Kosberg, CL
    Dickson, ER
    Kim, WR
    GASTROENTEROLOGY, 2001, 120 (05) : A76 - A77
  • [34] A model to predict survival in patients with end-stage liver disease
    Kamath, PS
    Wiesner, RH
    Malinchoc, M
    Kremers, W
    Therneau, TM
    Kosberg, CL
    D'Amico, G
    Dickson, ER
    Kim, WR
    HEPATOLOGY, 2001, 33 (02) : 464 - 470
  • [35] Risk factors and mortality in patients with listeriosis and end-stage renal disease
    Tran, Sarah Y.
    Barry, Sauveur
    Waller, Jennifer L.
    Bollag, Wendy B.
    Young, Lufei
    Padala, Sandeep
    Baer, Stephanie L.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 366 (04): : 263 - 269
  • [36] Liver transplant for 70 patients with end-stage liver diseases
    Jiang, Yi
    Lv, Li-Zhi
    Cai, Qiu-Cheng
    Zhang, Kun
    Hu, Huan-Zhang
    Zhang, Shao-Geng
    Yang, Fang
    Wei, Wei-Ming
    Zhang, Xiao-Jin
    Chen, Yong-Biao
    Pan, Fan
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2007, 6 (01) : 24 - 28
  • [38] Association of Model for End-Stage Liver Disease Score With Mortality in Emergency General Surgery Patients
    Havens, Joaquim M.
    Columbus, Alexandra B.
    Olufajo, Olubode A.
    Askari, Reza
    Salim, Ali
    Christopher, Kenneth B.
    JAMA SURGERY, 2016, 151 (07)
  • [39] Effects of Smoking on Survival for Patients with End-Stage Liver Disease
    Lee, Dennis S.
    Mathur, Amit K.
    Acker, William B., II
    Al-Holou, Shaza N.
    Ehrlichman, Lauren K.
    Lewin, Sarah A.
    Nguyen, Christopher K. B.
    Peterson, Sarah F.
    Ranney, David N.
    Sell, Kristen
    Kubus, James
    Englesbe, Michael J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (06) : 1077 - 1084
  • [40] Model for End-Stage Liver Disease Underestimates Morbidity and Mortality in Patients with Ascites Undergoing Colectomy
    Fleming, Matthew M.
    Liu, Fangfang
    Zhang, Yawei
    Pei, Kevin Y.
    WORLD JOURNAL OF SURGERY, 2018, 42 (10) : 3390 - 3397